Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

UV-A Protection Factor, Or APF

  • Read more about UV-A Protection Factor, Or APF
US Application 61/309,179
Filed on 2010-03-01

CP-690550-mediated Suppression Of An Antibody Response To A Foreign Protein (antibody-toxin Protein)

  • Read more about CP-690550-mediated Suppression Of An Antibody Response To A Foreign Protein (antibody-toxin Protein)
US Application 61/304,293
Filed on 2010-02-12

Improved Pepper Spray For Repellency And Incapacitation Of People And Animals

  • Read more about Improved Pepper Spray For Repellency And Incapacitation Of People And Animals
US Application 61/340,063
Filed on 2010-03-12

A New Type of GlycolipId Antigen Stimulating NKT Cells to Induce Anti-Tumor Immunity

  • Read more about A New Type of GlycolipId Antigen Stimulating NKT Cells to Induce Anti-Tumor Immunity
US Application 61/313,508
Filed on 2010-03-12

A Multifactorial Multidrug Resistance Gene Set Predicts Overall Survival In Ovarian Primary Serous Carcinoma

  • Read more about A Multifactorial Multidrug Resistance Gene Set Predicts Overall Survival In Ovarian Primary Serous Carcinoma
US Application 61/308,946
Filed on 2010-02-27

Prostate Tumor-Associcated Dendritic Cell Induction of Tolerance and Suppressor Activity in Tumor... -

  • Read more about Prostate Tumor-Associcated Dendritic Cell Induction of Tolerance and Suppressor Activity in Tumor... -
US Application 61/293,098
Filed on 2010-01-07

Modulating Immune Cell Activity Using Cylokine-induced Src Homology 2 And/Or High Temperature Requirement A-1

  • Read more about Modulating Immune Cell Activity Using Cylokine-induced Src Homology 2 And/Or High Temperature Requirement A-1
US Application 61/420,825
Filed on 2010-12-08

Device And Method For Ensuring The Accuracy Of A Tracking Device In A Volume

  • Read more about Device And Method For Ensuring The Accuracy Of A Tracking Device In A Volume
US Application 60/626,947
Filed on 2004-11-12

Use Of Cucurbitacins And Withanolides To Sensitize Cancer Cells To The Cytotoxic Effects Of Apo2L/TRAIL

  • Read more about Use Of Cucurbitacins And Withanolides To Sensitize Cancer Cells To The Cytotoxic Effects Of Apo2L/TRAIL
US Application 61/287,139
Filed on 2009-12-16

Development Of Novel Peptide Mimetic Ligands Of Polo-like Kinase 1 Polo Box Domain:Part 2

  • Read more about Development Of Novel Peptide Mimetic Ligands Of Polo-like Kinase 1 Polo Box Domain:Part 2
US Application 61/300,349
Filed on 2010-02-01

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 118
  • Page 119
  • Page 120
  • Page 121
  • Page 122
  • Page 123
  • Page 124
  • Page 125
  • Page 126
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health